Calibration Procedures for a Computational Model of Ductile Fracture

A recent extension of the Gurson constitutive model of damage and failure of ductile structural alloys accounts for localization and crack formation under shearing as well as tension. When properly calibrated against a basic set of experiments, this model has the potential to predict the emergence and propagation of cracks over a wide range of stress states. This paper addresses procedures for calibrating the damage parameters of the extended constitutive model. The procedures are demonstrated for DH36 steel using data from three tests: (i) tension of a round bar, (ii) mode I cracking in a compact tension specimen, and (iii) shear localization and mode II cracking in a shear-off specimen. The computational model is then used to study the emergence of the cup-cone fracture mode in the neck of a round tensile bar. Ductility of a notched round bar provides additional validation.Engineering and Applied Science

Raman Spectroscopic Analysis of Geological and Biogeological Specimens of Relevance to the ExoMars Mission

H.G.M.E., I.H., and R.I. acknowledge the support of the STFC Research Council in the UK ExoMars programme. J.J. and P.V. acknowledge the support of the Grant Agency of the Czech Republic (210/10/0467) and of the Ministry of Education of the Czech Republic (MSM0021620855).Peer reviewedPublisher PD

Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland

Background: Dried blood spot (DBS) testing for hepatitis C (HCV) was introduced to Scotland in 2009. This minimally invasive specimen provides an alternative to venipuncture and can overcome barriers to testing in people who inject drugs (PWID). Objectives: The objective of this study was to determine rates and predictors of: exposure to HCV, attendance at specialist clinics and anti-viral treatment initiation among the DBS tested population in Scotland. Study design: DBS testing records were deterministically linked to the Scottish HCV Clinical database prior to logistic regression analysis. Results: In the first two years of usage in Scotland, 1322 individuals were tested by DBS of which 476 were found to have an active HCV infection. Linkage analysis showed that 32% had attended a specialist clinic within 12 months of their specimen collection date and 18% had begun anti-viral therapy within 18 months of their specimen collection date. A significantly reduced likelihood of attendance at a specialist clinic was evident amongst younger individuals (<35 years), those of unknown ethnic origin and those not reporting injecting drug use as a risk factor. Conclusion: We conclude that DBS testing in non-clinical settings has the potential to increase diagnosis and, with sufficient support, treatment of HCV infection among PWID

A transient positive association between direct-acting antiviral therapy for hepatitis C infection and drug-related hospitalization among people who inject drugs: self-controlled case-series analysis of national data

Background and Aims: Direct-acting antiviral (DAA) treatment has an established positive effect on liver outcomes in people with hepatitis C infection; however, there is insufficient evidence regarding its effects on the 'extra-hepatic' outcomes of drug-related hospitalization and mortality (DRM) among people who inject drugs (PWID). We investigated associations between these outcomes and DAA treatment by comparing post-treatment to baseline periods using a within-subjects design to minimize selection bias concerns with cohort or case-control designs.Design: This was a self-controlled case-series study.Setting: Scotland, 1 January 2015-30 November 2020.Participants: The study population of non-cirrhotic, DAA-treated PWID was identified using a data set linking Scotland's hepatitis C diagnosis, HCV clinical databases, national inpatient/day-case hospital records and the national deaths register. Three principal outcomes (drug overdose admission, non-viral injecting related admission and drug-related mortality) were defined using ICD codes.Measurements: Self-controlled case-series methodology was used to estimate the relative incidence (RI) of each outcome associated with time on treatment and up to six 90-day exposure risk periods thereafter.Findings: A total of 6050 PWID were treated with DAAs in the sampling time-frame. Compared with the baseline period, there was a significantly lowered risk of a drug overdose hospital admission in the second to fifth exposure risk periods only [relative incidence (RI) = 0.86, 95% confidence interval (CI) = 0.80-0.99; 0.89, 95% CI = 0.80-0.99; 0.86, 95% CI = 0.77-0.96; 0.88, 95% CI = 0.78-0.99, respectively]. For non-viral injecting-related admission, there was a reduced risk in the first, third and fourth exposure risk periods (RI = 0.76, 95% CI = 0.64-0.90; 0.75, 95% CI = 0.62-0.90; 0.79, 95% CI = 0.66-0.96, respectively). There was no evidence for reduced DRM risk in any period following treatment end.Conclusions: Among people who inject drugs in Scotland, direct-acting antiviral treatment appears to be associated with a small, non-durable reduction in the risk of drug-related hospital admission, but not drug-related mortality. Direct-acting antiviral therapy, despite high effectiveness against liver disease, does not appear to offer a panacea for reducing other drug-related health harms.</p

Effect of N2, Ne and Ar seeding on Alcator C-Mod H-mode confinement

The mitigation of divertor heat fluxes is an active topic of investigation on existing tokamaks. One approach uses radiation, both inside and outside the last closed flux surface (LCFS), to convert plasma thermal energy, usually directed towards dedicated plasma facing components, to soft X-ray and ultraviolet radiation, spread over a much larger surface area. Recent enhanced D-α H-mode experiments on Alcator C-Mod varied the ICRF input power and radiative power losses via impurity seeding to demonstrate that normalized energy confinement depends strongly on the difference between input power and the radiated power inside the LCFS. These investigations also show that when seeded with either Ne or N2, a factor of two and higher reduction in outer divertor heat flux is achieved while maintaining H[subscript 98,y2] ∼ 1.0. Conversely, when seeding with Ar, confinement is limited to H[subscript 98,y2] ∼ 0.8 for a similar level of exhaust power.United States. Dept. of Energy (DOE Contract Number DEFC0299ER54512

Detection of reduced carbon in a basalt analogue for martian nakhlite : a signpost to habitat on Mars

C. W. Taylor and J. Still are thanked for skilled technical support. J. Parnell, H.G.M. Edwards, I. Hutchinson and R. Ingley acknowledge the support of the UKSA and the STFC Research Council in the UK ExoMars programme. L. V. Harris and S. McMahon acknowledge STFC studentship funding.Peer reviewedPublisher PD

Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale-up of direct-acting anti-viral therapy in community drug services:REAL WORLD DATA

BACKGROUND AND AIMS: There has been little empirical evidence to show the 'real-world' impact of scaling-up direct-acting anti-viral (DAA) treatment among people who inject drugs (PWID) on hepatitis C virus (HCV) viraemia at a population level. We aimed to assess the population impact of rapid DAA scale-up to PWID delivered through community services-including drug treatment, pharmacies, needle exchanges and prisons-in the Tayside region of Scotland, compared with Greater Glasgow and Clyde (GGC) and the Rest of Scotland (RoS). FINDINGS: Uptake of HCV therapy (last year) among PWID between 2013-14 and 2017-18 increased from 15 to 43% in Tayside, 6 to 16% in GGC and 11 to 23% in RoS. Between 2010 and 2017-18, the prevalence of HCV viraemia (among antibody-positives) declined from 73 to 44% in Tayside, 67 to 58% in GGC and 64 to 55% in RoS. The decline in viraemia was greater in Tayside [2017-18 adjusted odds ratio (aOR) = 0.47, 95% confidence interval (CI) = 0.30-0.75, P = 0.001] than elsewhere in Scotland (2017-18 aOR = 0.89, 95% CI = 0.74-1.07, P = 0.220) relative to the baseline of 2013-14 in RoS (including GGC). Per-protocol SVR rates among PWID treated in community sites did not differ from those treated in hospital sites in Tayside (97.4 versus 100.0%, P = 0.099). CONCLUSIONS: Scale-up of direct-acting anti-viral treatment among people who inject drugs can be achieved through hepatitis C virus (HCV) testing and treatment in community drug services while maintaining high sustained viral response rates and, in the Tayside region of Scotland, has led to a substantial reduction in chronic HCV in the population